Rocket Lab (NASDAQ:RKLB) Stock Falls 7.4% – Time to Sell?

Rocket Lab Corporation (NASDAQ:RKLB)’s stock price fell 7.4% during trading on Friday. The company traded as low as $53.19 and last traded at $54.73. Approximately 16,426,892 shares were traded during trading, a decline of 28% from the average session volume of 22,760,232 shares. The stock had previously closed at $59.10.

More Rocket Lab News

Here are the key news stories impacting Rocket Lab this week:

• Positive Sentiment: Rocket Lab continues to make operational progress: Neutron’s second stage and thrust module have reached Wallops Island, Virginia, for ground testing, while the company is preparing to ship its 100th Electron rocket. These milestones suggest development is advancing despite the launch delay. RKLB Stock Tests Bulls’ Patience
• Positive Sentiment: Analysts and bullish investors continue to point to Rocket Lab’s expanding business, including strong revenue growth, a reported $2.36 billion backlog, NASA-related opportunities, Iridium work and Mynaric exposure. Some forecasts argue that a successful Neutron milestone could eventually prompt a significant re-rating toward $100. Price Prediction: Rocket Lab Stock Will Hit $100
• Neutral Sentiment: The bullish investment thesis remains intact for some investors, but the Neutron delay changes the expected timing of revenue, launches and potential profitability. Rocket Lab’s substantial cash position and low leverage provide flexibility, though its high-growth valuation leaves the stock sensitive to schedule changes. The Neutron Delay Changes the Timeline, Not the Thesis
• Negative Sentiment: Investors are concerned that manufacturing defects in Neutron’s carbon-fiber structures—likened to trapped bubbles in a layered cake—contributed to the schedule slip. The delay increases execution risk and could lead to additional spending or dilution if development takes longer than expected. Rocket Lab Stock Lost Its Launch Date
• Negative Sentiment: An analyst fair-value estimate was trimmed from approximately $105.05 to $102.15, reflecting lower near-term expectations and greater execution risk following the Neutron delay. With Rocket Lab still unprofitable, investors are placing greater emphasis on delivery milestones rather than current earnings. Rocket Lab Fair Value Trim After Neutron Delay

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on RKLB shares. Raymond James Financial assumed coverage on shares of Rocket Lab in a report on Friday, September 11th. They issued an “outperform” rating and a $80.00 price target for the company. Citigroup restated a “market outperform” rating on shares of Rocket Lab in a research report on Friday, October 16th. Roth Capital reiterated a “buy” rating on shares of Rocket Lab in a research report on Thursday, October 15th. KGI Securities raised shares of Rocket Lab from a “neutral” rating to an “outperform” rating and set a $107.00 target price for the company in a research note on Monday, July 27th. Finally, Wall Street Zen downgraded Rocket Lab from a “hold” rating to a “sell” rating in a report on Saturday, August 15th. Three investment analysts have rated the stock with a Strong Buy rating, fourteen have given a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, Rocket Lab presently has a consensus rating of “Moderate Buy” and a consensus price target of $102.05.

Rocket Lab Stock Down 7.4%

The firm has a market cap of $32.75 billion, a P/E ratio of -202.70 and a beta of 2.93. The firm’s 50-day moving average price is $64.59 and its 200 day moving average price is $80.10. The company has a quick ratio of 4.98, a current ratio of 5.48 and a debt-to-equity ratio of 0.01.

Rocket Lab (NASDAQ:RKLB) last posted its quarterly earnings data on Monday, August 10th. The rocket manufacturer reported ($0.08) EPS for the quarter, missing analysts’ consensus estimates of ($0.06) by ($0.02). The firm had revenue of $234.07 million during the quarter, compared to the consensus estimate of $231.62 million. Rocket Lab had a negative return on equity of 6.48% and a negative net margin of 21.51%. As a group, research analysts expect that Rocket Lab Corporation will post -0.20 earnings per share for the current year.

Insider Transactions at Rocket Lab

In other news, CAO Agostino Ricupati sold 669 shares of the firm’s stock in a transaction that occurred on Monday, August 24th. The stock was sold at an average price of $69.63, for a total value of $46,582.47. Following the transaction, the chief accounting officer owned 26,863 shares in the company, valued at $1,870,470.69. This trade represents a 2.43% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, SVP Arjun Kampani sold 6,034 shares of the business’s stock in a transaction on Thursday, August 27th. The shares were sold at an average price of $66.65, for a total value of $402,166.10. Following the completion of the sale, the senior vice president owned 250,917 shares in the company, valued at approximately $16,723,618.05. The trade was a 2.35% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 400,749 shares of company stock worth $26,964,474. Company insiders own 8.40% of the company’s stock.

Institutional Inflows and Outflows

Hedge funds have recently bought and sold shares of the business. Versant Capital Management Inc lifted its holdings in Rocket Lab by 5.1% during the second quarter. Versant Capital Management Inc now owns 2,049 shares of the rocket manufacturer’s stock valued at $208,000 after purchasing an additional 100 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its position in shares of Rocket Lab by 7.1% during the first quarter. Bartlett & CO. Wealth Management LLC now owns 1,869 shares of the rocket manufacturer’s stock valued at $120,000 after buying an additional 124 shares during the period. Parvin Asset Management LLC boosted its stake in shares of Rocket Lab by 4.0% during the first quarter. Parvin Asset Management LLC now owns 3,665 shares of the rocket manufacturer’s stock valued at $235,000 after purchasing an additional 140 shares during the period. Wedmont Private Capital increased its position in shares of Rocket Lab by 3.5% during the third quarter. Wedmont Private Capital now owns 4,644 shares of the rocket manufacturer’s stock worth $318,000 after acquiring an additional 157 shares during the period. Finally, DMC Group LLC lifted its stake in Rocket Lab by 5.0% in the second quarter. DMC Group LLC now owns 3,553 shares of the rocket manufacturer’s stock worth $361,000 after acquiring an additional 170 shares during the period. Hedge funds and other institutional investors own 71.78% of the company’s stock.

About Rocket Lab

Rocket Lab USA, Inc is a space and defense company that develops and operates launch vehicles, spacecraft, satellite components and related space systems. The company serves government, commercial and scientific customers seeking access to orbit and other space-based capabilities.

Rocket Lab’s launch business is centered on Electron, a small orbital launch vehicle designed to carry satellites and other payloads into low Earth orbit. The company also develops specialized launch and hypersonic test services through programs such as HASTE, while its Neutron vehicle is intended to provide larger payload capacity and support future commercial and government missions.

Through its space systems business, Rocket Lab produces satellite platforms, flight computers, power systems, solar cells, reaction wheels, separation systems, radios and other components used in spacecraft.